Novartis Venture Fund and Sanofi Ventures are among the four investors that co-led Expansion Therapeutics' $55.3m series A round.
US-based precision medicine developer Expansion Therapeutics closed a $55.3m series A round yesterday co-led by subsidiaries of pharmaceutical groups Novartis and Sanofi.
Novartis Venture Fund and Sanofi Ventures co-led the round with venture capital firms 5AM Ventures and Kleiner Perkins Caufield Byers (KPCB), while RA Capital Management and Alexandria Venture Investments, the VC arm of life sciences real estate trust Alexandria Real Estate Equities, also took part.
Expansion aims to develop small molecule drugs to tackle expansion repeat disorders, a…
